Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4675 studies found for:    "complement factor I deficiency" OR "Immunologic Deficiency Syndromes"
Show Display Options
Rank Status Study
1 Completed
Has Results
A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency
Condition: Immunologic Deficiency Syndrome
Intervention: Biological: Immune Globulin Intravenous (Human)
2 Completed Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency
Condition: Immunologic Deficiency Syndrome
Intervention: Drug: Immune Globulin Intravenous (Human) 5% Liquid, IVIG-SN™
3 Recruiting Genetic Basis of Primary Immunodeficiencies
Condition: Immunologic Deficiency Syndrome
Intervention:
4 Recruiting Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies
Condition: Immunologic Deficiency Syndromes
Interventions: Procedure: blood sampling and skin biopsy;   Procedure: blood sampling or mouth swap;   Procedure: blood sampling
5 Terminated Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases
Condition: Immunologic Deficiency Syndromes
Intervention: Drug: Octagam 10%
6 Recruiting Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Condition: Immunologic Deficiency Syndromes
Intervention: Biological: GC5107
7 Enrolling by invitation Molecular and Clinical Studies of Primary Immunodeficiency Diseases
Condition: Immunologic Deficiency Syndrome
Intervention:
8 Recruiting Early Diagnosis and Stem Cell Transplantation for Severe Immunodeficiency Diseases
Condition: Severe Immunodeficiency Diseases
Intervention: Drug: Fludarabine, Busulfan, and Anti-Thymocyte Globulin
9 Enrolling by invitation Clinical and Laboratory Online Patient- and Research Database for Primary Immunodeficiencies in Switzerland
Condition: Primary Immunodeficiency Disease
Intervention:
10 Not yet recruiting IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia
Condition: Primary Immunodeficiency
Intervention: Drug: IgHy10
11 Recruiting Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps
Condition: Primary Immunodeficiency (PID)
Intervention: Biological: Gammanorm
12 Completed Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency
Condition: Primary Immune Deficiency
Intervention: Drug: Immunoglobulin G (Ig NextGen 16%)
13 Not yet recruiting Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiencies
Condition: Severe Combined Immunodeficiency
Intervention: Biological: TBX-1400
14 Not yet recruiting ASIS for GAMMAGARD in Primary Immunodeficiency
Condition: Primary Immunodeficiency
Interventions: Drug: Gadolinium For abdomen;   Drug: Gadolinium For lower back;   Drug: Efficacy of Gammagard subcutaneously at Week 12;   Drug: Efficacy of Gammagard subcutaneously at Week 24;   Drug: Efficacy of Gammagard subcutaneously at Week 36;   Drug: Efficacy of Gammagard subdermally at Week 36;   Drug: Efficacy of Gammagard subdermally at Week 12;   Drug: Efficacy of Gammagard subdermally at Week 24;   Drug: Adverse Reactions of Gammagard subcutaneously at Week 12;   Drug: Adverse Reactions of Gammagard subcutaneously at Week 24;   Drug: Adverse Reactions of Gammagard subcutaneously at Week 36;   Drug: Adverse Reactions of Gammagard subdermally at Week 12;   Drug: Adverse Reactions of Gammagard subdermally at Week 24;   Drug: Adverse Reactions of Gammagard subdermally at Week 36
15 Completed Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)
Condition: Primary Immune Deficiency
Intervention: Biological: Immune globulin subcutaneous (Human)
16 Recruiting Intensive Care Unit and Secondary and Primary Immune Deficiency
Condition: Primary Immune Deficiency Disorder
Intervention: Other: Internal Medicine consultation
17 Not yet recruiting Hematopoietic Stem Cells Transplantation in Children With Combined Immunodeficiency (CID)
Condition: Combined Immunodeficiencies
Intervention: Biological: Depletion in CD45RA graft donor
18 Completed Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome
Condition: Severe Combined Immunodeficiency
Interventions: Procedure: Stem cell transplant;   Drug: Filgrastim, Alemtuzumab;   Device: Miltenyi CliniMACS
19 Recruiting Genetic Basis of Immunodeficiency
Condition: Severe Combined Immunodeficiency
Intervention:
20 Recruiting Donor Stem Cell Transplantation for Congenital Immunodeficiencies
Condition: Inherited Immune Deficiencies
Interventions: Drug: Fludarabine;   Drug: Total Body Irradiation, Busulfan, Campath-1H, or h-ATG, Fludarabine;   Drug: Sirolimus or equivalent based on response;   Drug: Granulocyte Colony Stimulating Factor (G-CSF);   Other: hematopoietic progenitor cells

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.